News

NAVLIN DAILY
navlindaily.com > article > 31254 > india-s-drug-discovery-pipeline-tops-1-095-programs-report

NAVLIN DAILY

10+ hour, 10+ min ago  (11+ words) India's Drug Discovery Pipeline Tops 1,095 Programs: Report NAVLIN DAILY...

NAVLIN DAILY
navlindaily.com > article > 30170 > pharmaceutical-spending-in-spain-up-55-since-2015-regional-gaps-widen

Pharmaceutical Spending in Spain Up 55% Since 2015, Regional Gaps Widen

3+ mon, 6+ day ago  (65+ words) Redefining the QA Role in the Age of AI SIUU vs. Unsolicited Off‑Label Requests: A Practical Comparison The Integrated Advantage: What Medical Affairs Needs Right Now Solving The Rare Disease Launch Paradox — Using Pre‑Launch Planning and Partnership to…...

NAVLIN DAILY
navlindaily.com > article > 30009 > denmark-recommends-2-drugs-rejects-4

Denmark Recommends 2 Drugs & Rejects 4

3+ mon, 2+ week ago  (80+ words) Solving The Rare Disease Launch Paradox — Using Pre‑Launch Planning and Partnership to Create Value EVERSANA’s AI Agency Platform Wins 2026 AI Excellence Award It’s Time for Commercialization to Catch Up to Innovation in Women’s Health 4th Annual Brand Planning Report: Fueling…...

NAVLIN DAILY
navlindaily.com > article > 29832 > virginia-lawmakers-replace-pdab-bill-with-new-legislation-to-tackle-prescription-drug-prices

Virginia Lawmakers Replace PDAB Bill with New Legislation to Tackle Prescription Drug Prices

4+ mon, 4+ day ago  (59+ words) Gartner Is Right — About the Wrong Kind of Agency AI Platform Advancing Medical Affairs Through Data and Scientific Communications: Key Takeaways from DIA MASC 2026 Scaling Practical AI Across Commercial Teams Key Implications of Recent U.S. PBM Reforms Building a scalable…...

NAVLIN DAILY
navlindaily.com > article > 29805 > jamaican-regulator-orders-divestment-for-30-billion-insulin-market

Jamaican Regulator Orders Divestment for $30 Billion+ Insulin Market

4+ mon, 6+ day ago  (61+ words) Key Implications of Recent U.S. PBM Reforms Building a scalable GLP-1 care model Navigating the Intersection of AI, Global Commercialization and Patient Value Recognizing Rare Disease Day: Advancing Hope, Access and Innovation Why Our AI Agency Is So Much More Than…...

NAVLIN DAILY
navlindaily.com > article > 29798 > kazakhstan-targets-38-new-meds-by-2029-to-boost-domestic-drug-production

Kazakhstan Targets 38 New Meds by 2029 to Boost Domestic Drug Production

4+ mon, 6+ day ago  (61+ words) Key Implications of Recent U.S. PBM Reforms Building a scalable GLP-1 care model Navigating the Intersection of AI, Global Commercialization and Patient Value Recognizing Rare Disease Day: Advancing Hope, Access and Innovation Why Our AI Agency Is So Much More Than…...

NAVLIN DAILY
navlindaily.com > article > 29794 > eu-pharma-reform-introduces-three-year-launch-obligation-for-medicines

EU Pharma Reform Introduces Three-year Launch Obligation for Medicines

4+ mon, 6+ day ago  (632+ words) BRUSSELS, Belgium — The EU has set out the terms of a new launch obligation for medicines, requiring pharmaceutical companies to make approved drugs available in requesting Member States within three years or risk losing regulatory market protection in that country....

NAVLIN DAILY
navlindaily.com > article > 29753 > uzbekistan-moves-to-accelerate-pharma-localization-with-new-incentives

Uzbekistan Moves to Accelerate Pharma Localization with New Incentives

4+ mon, 1+ week ago  (67+ words) Building a scalable GLP-1 care model Navigating the Intersection of AI, Global Commercialization and Patient Value Recognizing Rare Disease Day: Advancing Hope, Access and Innovation Why Our AI Agency Is So Much More Than ChatGPT for Life Sciences Marketing Demonstrating…...

NAVLIN DAILY
navlindaily.com > article > 29745 > second-annual-minnesota-340b-report-shows-large-hospitals-continue-to-make-up-largest-share-of-program

Second Annual Minnesota 340B Report Shows Large Hospitals Continue to Make up Largest Share of Program

4+ mon, 1+ week ago  (67+ words) Building a scalable GLP-1 care model Navigating the Intersection of AI, Global Commercialization and Patient Value Recognizing Rare Disease Day: Advancing Hope, Access and Innovation Why Our AI Agency Is So Much More Than ChatGPT for Life Sciences Marketing Demonstrating…...

NAVLIN DAILY
navlindaily.com > article > 29654 > phrma-pushes-back-on-trump-administration-s-calls-to-codify-mfn

PhRMA Pushes Back on Trump Administration’s Calls to Codify MFN

4+ mon, 2+ week ago  (271+ words) WASHINGTON, DC, United States – U.S. President Donald Trump once again called on lawmakers to codify his Most Favored Nation (MFN) drug pricing deals during his State of the Union address on Tuesday. However, the pharmaceutical industry does not appear convinced....